Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

HaloPROTAC3

Copy Product Info
😃Good
Catalog No. T32043Cas No. 1799506-07-2
Alias HaloPROTAC-3, HaloPROTAC 3, Halo PROTAC-3

HaloPROTAC3 (HaloPROTAC-3) is a conjugate of ligands for E3 and 16-atom-length linker and a degrader of HaloTag fusion proteins.

HaloPROTAC3

HaloPROTAC3

Copy Product Info
😃Good
Purity: 99.76%
Catalog No. T32043Alias HaloPROTAC-3, HaloPROTAC 3, Halo PROTAC-3Cas No. 1799506-07-2
HaloPROTAC3 (HaloPROTAC-3) is a conjugate of ligands for E3 and 16-atom-length linker and a degrader of HaloTag fusion proteins.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$112In StockIn Stock
5 mg$278In StockIn Stock
10 mg$455-In Stock
25 mg$753-In Stock
50 mg$1,060-In Stock
100 mg$1,430-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.76%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
HaloPROTAC3 (HaloPROTAC-3) is a conjugate of ligands for E3 and 16-atom-length linker and a degrader of HaloTag fusion proteins.
In vitro
HaloPROTAC 3 is an efficacious GFP-HaloTag7 degrader (DC50 = 19 nM). HaloPROTAC 3(625 nM) induces 90 % degradation of GFP-Halotag. HaloPROTAC 3 binds to VHL with an IC50 of 0.54 μM[1].
SynonymsHaloPROTAC-3, HaloPROTAC 3, Halo PROTAC-3
Chemical Properties
Molecular Weight799.42
FormulaC41H55ClN4O8S
Cas No.1799506-07-2
Smiles[C@@H](C(=O)N1[C@H](C(NCC2=C(OCCOCCOCCOCCCCCCCl)C=C(C=C2)C3=C(C)N=CS3)=O)C[C@@H](O)C1)(C(C)C)N4C(=O)C=5C(C4)=CC=CC5
Relative Density.1.250 g/cm3 (Predicted)
Storage & Solubility Information
Storagekeep away from direct sunlight | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 83.14 mg/mL (104 mM), Sonication and heating are recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (4.13 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.2509 mL6.2545 mL12.5091 mL62.5453 mL
5 mM0.2502 mL1.2509 mL2.5018 mL12.5091 mL
10 mM0.1251 mL0.6255 mL1.2509 mL6.2545 mL
20 mM0.0625 mL0.3127 mL0.6255 mL3.1273 mL
50 mM0.0250 mL0.1251 mL0.2502 mL1.2509 mL
100 mM0.0125 mL0.0625 mL0.1251 mL0.6255 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy HaloPROTAC3 | purchase HaloPROTAC3 | HaloPROTAC3 cost | order HaloPROTAC3 | HaloPROTAC3 chemical structure | HaloPROTAC3 in vitro | HaloPROTAC3 formula | HaloPROTAC3 molecular weight